| Description |
1 online resource (443 pages) |
| Contents |
Cover; Half Title; Title Page; Copyright Page; Contents; Preface; Foreword; Contributors; Part 1: Congenital Vascular Malformations (CVMs) in General; Section 1: Definition and Classification; 1. ISSVA classification: Controversy with the benefit and liability; 2. Hamburg classification: Controversy with the benefit and liability; 3. Syndromic classification of congenital vascular malformations: How useful is it?; 4. Consensus on contemporary classification; Section 2: Diagnosis; 5. How extensive study should be included in initial assessment for congenital vascular malformations |
|
6. Should hemangiomas be included in initial differential diagnosis for congenital vascular malformations?7. To what extent should genetic studies be incorporated for assessment of venous and arteriovenous malformations, and when?; 8. Indications for genetic testing in evaluation of lymphatic and hemolymphatic malformations; Section 3: Management; 9. Importance of interdisciplinary team approach for evaluation and management of vascular malformations; 10. How will genetics influence management of vascular malformations?; Part 2: Arteriovenous Malformations (AVMs) |
|
Section 4: Definition and Classification11. Confusion with arteriovenous fistula versus arteriovenous malformation of ISSVA classification; 12. Nidus or no nidus: Is it a crucial issue for diagnostic assessment of arteriovenous malformations?; 13. New classification of arteriovenous malformations based on angiographic findings: What are the advantages?; Section 5: Diagnosis; 14. Arteriographic assessment: Is it still the gold standard for diagnosis of arteriovenous malformations?; 15. Ultrasonographic assessment: New role for arteriovenous malformations. How far can it be implied? |
|
16. Magnetic resonance angiography and/or computed tomography angiography: New gold standard for arteriovenous malformations?17. Transarterial lung perfusion scintigraphy (TLPS): New role for follow-up assessment?; Section 6: Management: 1; 18. Do all the arterio-venous malformations mandate the therapy? Is there any contraindication for the therapy?; 19. How much is too much for arteriovenous malformation management?; 20. Ethanol sclerotherapy: Is it gold standard for arteriovenous malformation management?; 21. N-butyl cyanoacrylate versus Onyx embolotherapy; Section 7: Management: 2 |
|
22. Surgical therapy combined with embolo-/sclerotherapy: Multidisciplinary approach23. Indications for amputation in patients with arterio-venous malformations; 24. How much pharmacological therapy can be incorporated into arteriovenous malformation management?; 25. Secondary changes in arteriovenous malformations: Arteries, veins, tissues, bones, when do they have to be treated?; Part 3: Venous Malformations; Section 8: Definition and Classification; 26. Capillary and cavernous hemangioma and venous malformations |
| Notes |
27. Angiographic classification of venous malformations based on venous drainage status: What are the advantages? |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| Subject |
Cerebrovascular disease.
|
|
Brain -- Congestion.
|
|
Stroke
|
|
Cerebrovascular Disorders
|
|
Brain -- Congestion
|
|
Cerebrovascular disease
|
| Form |
Electronic book
|
| Author |
Gloviczki, Peter
|
|
Francine, Blei
|
| ISBN |
9781000731606 |
|
100073160X |
|
9781000731880 |
|
100073188X |
|
9781000731743 |
|
100073174X |
|
9780367255343 |
|
0367255340 |
|
